Linavonkibart

利沃奇拜单抗

Report date: 2024/05/17 16:18:15

Base Information

Drug NameLinavonkibart

Drug Alias NameNiche modulators (Scholar Rock)SRK-181SRT-BETA-1-AB3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionTransforming growth factor beta 1 inhibitors

TargetsTransforming growth factor beta 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesScholar Rock Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A